Catalio Nexus
Startup rounds since 2019 with a Catalio Nexus investor on the board, and the firm's own fund filings.
Raises
13
since 2019
Unannounced
3
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Iambic Therapeutics, Inc.$66M
- NextPoint Therapeutics, Inc.$33.7M
- Iambic Therapeutics, Inc.$27.8M
- Iambic Therapeutics, Inc.$99.3M
- Iambic Therapeutics, Inc.$38.4M
- NextPoint Therapeutics, Inc.$42.5M
- ManaT Bio, Inc.$72.1M
- Iambic Therapeutics, Inc.$103M
- Haystack Oncology, Inc.$67M
- eNeura, INC.$511K
- eNeura, INC.$5.91M
- eNeura, INC.$200K
- eNeura, INC.$15M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 3 | 3 |
| 2025 | 1 | 0 |
| 2024 | 2 | — |
| 2023 | 2 | — |
| 2022 | 1 | — |
| 2020 | 1 | — |
| 2019 | 3 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Catalio Nexus Fund III, LP | 11 Jul 2022 | $384M | $384M |
Listed because a Catalio Nexus fund's filing names a director of each company. A name match is not a verified identity.